Go to Pathways list
Support our work
DONATE NOW

PARP inhibitors in primary and recurrent ovarian cancer

E-session 508 / CME accredited Add to My Agenda

Expert:

Mansoor Raza Mirza, expert of session 'PARP inhibitors in primary and recurrent ovarian cancer'

Mansoor Raza Mirza
Rigshospitalet
Copenhagen, Denmark

Discussant:

Mikkel Rosendahl, expert of session 'PARP inhibitors in primary and recurrent ovarian cancer'

Mikkel Rosendahl
Rigshospitalet
Copenhagen, Denmark

Share on:

This session is part of the following pathway(s):

GYNAECOLOGY: Ovarian cancer

12
Dec 2019
18:15-19:00 CET

Top